Patent intelligence · WO
WO 2007147454
SYNTHÈSE CHIMIQUE DE LA CU-64ASP (CUIVRE-64ASPARAGINASE ; [64CU]ASPARARAGINASE) POUR PET SCAN ET RADIOTHÉRAPIE
SYNTHÈSE CHIMIQUE DE LA CU-64ASP (CUIVRE-64ASPARAGINASE ; [64CU]ASPARARAGINASE) POUR PET SCAN ET RADIOTHÉRAPIE
Patent details — WO 2007147454
- Jurisdiction
- WO
- Status
- granted
- Grant date
- Dec 27, 2007
- Expiration
- Dec 22, 2027
- Applicant
- A C O M ADVANCED CT ONCOLOGY M [IT]
- CPC classes
- A61K 51/ 08 A I, A61K/4760, A61K/51088
Quick answer
WO 2007147454 (SYNTHÈSE CHIMIQUE DE LA CU-64ASP (CUIVRE-64ASPARAGINASE ; [64CU]ASPARARAGINASE) POUR PET SCAN ET RADIOTHÉRAPIE) is held by A C O M ADVANCED CT ONCOLOGY M [IT]. Status: granted. Granted Dec 27, 2007. Expires Dec 22, 2027 (2 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- A C O M ADVANCED CT ONCOLOGY M [IT]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 51/ 08 A I, A61K/4760, A61K/51088
Frequently asked questions
What is US patent 2007147454?
WO 2007147454 (SYNTHÈSE CHIMIQUE DE LA CU-64ASP (CUIVRE-64ASPARAGINASE ; [64CU]ASPARARAGINASE) POUR PET SCAN ET RADIOTHÉRAPIE) is held by A C O M ADVANCED CT ONCOLOGY M [IT]. Status: granted. Granted Dec 27, 2007. Expires Dec 22, 2027 (2 years remaining) — relevant for patent-cliff and LOE planning.
Who owns WO 2007147454?
A C O M ADVANCED CT ONCOLOGY M [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1 pharmaceutical patents for this assignee.
When does WO 2007147454 expire?
Our index shows an expiration date of Dec 22, 2027 (2 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.